These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target. Ma S; Paiboonrungruan C; Yan T; Williams KP; Major MB; Chen XL Ann N Y Acad Sci; 2018 Dec; 1434(1):164-172. PubMed ID: 29752726 [TBL] [Abstract][Full Text] [Related]
6. Alcohol drinking inhibits NOTCH-PAX9 signaling in esophageal squamous epithelial cells. Shi M; Ren S; Chen H; Li J; Huang C; Li Y; Han Y; Li Y; Sun Z; Chen X; Xiong Z J Pathol; 2021 Apr; 253(4):384-395. PubMed ID: 33314197 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-23 receptor signaling mediates cancer dormancy and radioresistance in human esophageal squamous carcinoma cells via the Wnt/Notch pathway. Zhou Y; Su Y; Zhu H; Wang X; Li X; Dai C; Xu C; Zheng T; Mao C; Chen D J Mol Med (Berl); 2019 Feb; 97(2):177-188. PubMed ID: 30483821 [TBL] [Abstract][Full Text] [Related]
9. WNT and NOTCH signaling pathways as activators for epidermal growth factor receptor in esophageal squamous cell carcinoma. Abbaszadegan MR; Riahi A; Forghanifard MM; Moghbeli M Cell Mol Biol Lett; 2018; 23():42. PubMed ID: 30202417 [TBL] [Abstract][Full Text] [Related]
10. Jag1/2 maintain esophageal homeostasis and suppress foregut tumorigenesis by restricting the basal progenitor cell pool. Huang H; Jiang Y; Liu J; Luo D; Yuan J; Mu R; Yu X; Sun D; Lin J; Chen Q; Li X; Jiang M; Xu J; Chu B; Yin C; Zhang L; Ye Y; Cao B; Wang Q; Zhang Y Nat Commun; 2024 May; 15(1):4124. PubMed ID: 38750026 [TBL] [Abstract][Full Text] [Related]
11. Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett's esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors. Carrossini N; Meireles Da Costa N; Andrade-Barreto E; Sousa VPL; Nicolau-Neto P; Souza-Santos PT; Mansur GR; Wernersbach L; Bozza PT; Viola JPB; Ribeiro Pinto LF Sci Rep; 2021 Jan; 11(1):981. PubMed ID: 33441691 [TBL] [Abstract][Full Text] [Related]
12. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma. Zhang J; Liu S; Zhang D; Ma Z; Sun L J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888 [TBL] [Abstract][Full Text] [Related]
13. FLI-06 suppresses proliferation, induces apoptosis and cell cycle arrest by targeting LSD1 and Notch pathway in esophageal squamous cell carcinoma cells. Lu Z; Ren Y; Zhang M; Fan T; Wang Y; Zhao Q; Liu HM; Zhao W; Hou G Biomed Pharmacother; 2018 Nov; 107():1370-1376. PubMed ID: 30257352 [TBL] [Abstract][Full Text] [Related]
14. Gli1 interacts with YAP1 to promote tumorigenesis in esophageal squamous cell carcinoma. Wang C; Cheng L; Song S; Wu S; Sun G J Cell Physiol; 2020 Nov; 235(11):8224-8235. PubMed ID: 31957872 [TBL] [Abstract][Full Text] [Related]
15. Roles of the hexosamine biosynthetic pathway and pentose phosphate pathway in bile acid-induced cancer development. Munemoto M; Mukaisho KI; Miyashita T; Oyama K; Haba Y; Okamoto K; Kinoshita J; Ninomiya I; Fushida S; Taniura N; Sugihara H; Fujimura T Cancer Sci; 2019 Aug; 110(8):2408-2420. PubMed ID: 31215094 [TBL] [Abstract][Full Text] [Related]
16. miR-145 Regulates the sensitivity of esophageal squamous cell carcinoma cells to 5-FU via targeting REV3L. Chen Q; Hou J; Wu Z; Zhao J; Ma D Pathol Res Pract; 2019 Jul; 215(7):152427. PubMed ID: 31072625 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma through blockade of the LIMK1/cofilin signaling pathway by binding to LIMK1. Yu HX; Wang XL; Zhang LN; Zhang J; Zhao W Biomed Pharmacother; 2019 Jan; 109():751-761. PubMed ID: 30551528 [TBL] [Abstract][Full Text] [Related]
18. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation. Jing C; Li X; Zhou M; Zhang S; Lai Q; Liu D; Ye B; Li L; Wu Y; Li H; Yue K; Chen P; Yao X; Wu Y; Duan Y; Wang X Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885 [TBL] [Abstract][Full Text] [Related]
19. MTA1 promotes tumorigenesis and development of esophageal squamous cell carcinoma via activating the MEK/ERK/p90RSK signaling pathway. Nan P; Wang T; Li C; Li H; Wang J; Zhang J; Dou N; Zhan Q; Ma F; Wang H; Qian H Carcinogenesis; 2020 Sep; 41(9):1263-1272. PubMed ID: 31783401 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-429 inhibits the proliferation and migration of esophageal squamous cell carcinoma cells by targeting RAB23 through the NF-κB pathway. Wang Y; Yu XJ; Zhou W; Chu YX Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1202-1210. PubMed ID: 32096149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]